Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumor cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis
Agena Bioscience to provide Horizon’s human genomic reference standards to assess quality and performance of oncology-based assays on the MassARRAY System
iPLEX® HS chemistry enables multiplex detection down to 1% allele frequency
New platform enables researchers to rapidly identify cutting-edge anti-cancer drugs
Researchers’ use of ParsortixTM System for studies into multiple cancers confirms the cell separation technology’s ability to harvest viable circulating tumor cells for a broad range of downstream analyses
RNA-seq Explorer Solution generates clear insights for cancer ‘omics’ analyses
In vitro diagnostic approved to support use of Bristol-Myers Squibb’s OPDIVO® for non-squamous non-small cell lung cancer
Share your expertise and vote for the product that made most difference to your research in 2015
Discover SelectScience® video interviews and articles about the latest Alzheimer’s disease research methods
SelectScience® brought a grand piano to the Pittcon show floor for the first time ever
Analyzing 50-year old DNA from highly complex samples
The new technology speeds up in-database, large-scale analyses by a factor of approximately 400, helping to advance genomic medical research
TATAA Biocenter also to introduce Swift Biosciences’ NGS products in its popular NGS training courses
Shimadzu’s new protein sequencers offer enhanced sensitivity and compliance with FDA
Maximizes CRISPR gene editing efficiency and lowers the risk of off-target effects
DeNovix Inc. launches the Ultra High Sensitivity dsDNA fluorescence quantification assay
Company to share latest advances at pathology congress
